Talking about MON, USB, WFC, WDC, RIMM, AAPL... you can see how well they did since october 13th...
For Louis Navellier it was a good day to buy with S&P500 at 1003 (now at 868).
(In)Famous last words from Stock Market Experts that help you burn your money. Remember: you can often ask your money back if their advice is useless...
Palm Beach, Florida 10:03AM EST
Our success has been your opportunity, my dear colleague…
…and tonight that opportunity must end.
Our top Quantum Growth stocks thrashed the market in 2008, so I’ve slashed the price of Quantum Growth in half, given an unprecedented 100% money-back guarantee—and restricted the offer to 1,000 Qualified Investors like you.
I couldn't read anything more of this crap.
I just want to remind you how Quantum Growth slashed the market.
I will post the full year performance next week for Quantum Growth and Global Growth, compared to the S&P500. And I will forward it to Bloomberg, CNN Money and other Financial websites.
I hate this crap.
Mr. Hsu was writing between October and November 2007:
After watching FMCN going down for 1 year (red line in chart is a beautiful down-trend) Mr. Hsu decided that it is time to sell it:
We first invested in Focus Media (NASDAQ: FMCN) back in November 2005. At that time, the company had recently gone public, and was growing rapidly by installing advertising screens in buildings, shopping malls and supermarkets across China. In all my visits to China, I've always been thoroughly impressed with the company's advertising screens and the reactions they received from people.
Unfortunately, in the past year, the company has fallen on hard times, as the financial crisis and global economic slowdown pulled down companies' shares across the board. In addition, Focus Media is suffering from competitors who mimic Focus Media's video billboard strategy, as well as the fact that advertising budgets have been cut across the globe.
In light of these recent developments, I think it is now time to sell Focus Media. The stock has recently rallied 30% off its lows, and I think we should use this rally to sell our shares. Sell FMCN.
The close price yesterday was $9.20 and the loss for Mr. Hsu is 34%.
Mr. Hsu provided another lesson about how to turn a 360% gain ($14 to $65) into a 34% loss.
A final word about those subscribers that followed him on November 2007 and bought FMCN at $60.
They lost 84%!!!
What's next
Currently FMCN is positioned as follow among its industry peers:
Best 40% as P/E
Best 20% as ROA and ROI
Best 20% as Quick and Current Ratio
Best 20% as OM, EBITDA and Profit Margin
Best 20% as Sales Growth
Add the fact that Mr. Hsu is selling and it may really be the right time to buy...
UPDATE November 19th, market close
As I said... yesterday Mr. Hsu was saying "Sell FMCN" and today FMCN gained over 19%... what a genius!!!
Here is how NOK (blue) beated the S&P500 (red)
ASIA went to $12.50. Mr. Hsu wrote yesterday:
The time has come to sell AsiaInfo Holdings (NASDAQ: ASIA).
As you know, I first recommended this Chinese technology company back in July, as a way to take advantage of the major restructuring among Chinese telecoms. While the AsiaInfo bounced nicely following my recommendation, it sold off this fall with the rest of the global markets.
After experiencing nearly a 40% decline since September, I placed AsiaInfo on hold in early October and told you that we would likely sell the stock into a bounce later in the year. And on November 5 after the company reported decent third-quarter results, I recommended placing a limit order on the stock to sell it above $12.50.
Well, during today's market rally -- Hong Kong's Hang Seng index gained more than 8% -- AsiaInfo jumped nearly 4% and tripped our $12.50 limit order. That's why I want you to sell ASIA if you haven't already done so. And I'll have more details in this Wednesday's Asia Edge.
A very modest loss of only 7% for Mr. Hsu. One of his best performance of 2008 (at least compared to CTRP, SOHU, QCOM, FMCN, DRYS and others).
Cheers!
Mr. Navellier decided you should have bought XTLB.
August 18th: buy below $4.28
August 25th: Newcomers to the list fared particularly well. XTL Biopharmaceuticals (XTLB), which I told you to buy just two weeks ago, finished the week up almost 9%. Buy below $4.85
September 2nd: [...] don't think our portfolio is one-dimensional–one of our recent health care buys, XTL Biopharmaceuticals (XTLB), jumped almost 10% last week, giving us a total return of almost 22% since I recommended this stock on August 11! [...] Buy below $5.16
September 8th: Just look at XTLB up nearly 20% in less than a month! [...] Top Three Stocks [...] and Israel's XTL Biopharmaceuticals (XTLB) moves up to the #3 spot. XTLB has posted gains of almost 20% in less than a month! Buy below $4.74
September 15th: buy below $4.11
September 22nd: buy below $4.14
September 29th: buy below $3.79
October 6th: buy below $3.42
October 13th: buy below $2.65
October 20th: buy below $3.05
October 27th: buy below $2.90
November 3rd: buy below $3.00
November 10th: buy below $3.06
November 17th: buy below $3.00
November 24th: I'll get to the details in just a bit, but while we're on the subject of our Buy List, we did have one unfortunate surprise last week. On Tuesday, XTL Biopharmaceuticals (XTLB) saw its stock price drop from $2.10 to 13 cents after the company announced that its diabetic pain treatment drug failed crucial tests. In this week's issue, I'll tell you what to do now with this stock.
This week, I recommend selling [...] and Israel's XTL Biopharmaceuticals (XTLB). I referenced earlier in the issue that XTLB fell 94% on Tuesday after the company said its diabetic-pain treatment missed its primary and secondary benchmarks in a clinical trial. In my blog, I initially said to wait to hear from the CEO before rushing to sell. Well, it's been almost a week now, and we haven't heard a thing. With the failure of XTLB's lead candidate, the company is now too far behind to have any real chance of generating revenue, so this leaves us no choice but to sell shares now for a year-end tax loss.
Sell price: around 8 cents.
Loss: 97.8% (NEW RECORD!!!)
As every Monday, Louis Navellier sent his $5.000/year Quantum Growth paying subscribers detailed instruction about FSYS and NCS.
Both of these stocks were bought only 2 weeks ago, so we cannot enjoy Navellier's typical rollercoaster ride (with usual sell at the bottom...).
Very quickly, here is NCS.
It was bought on November 17th at $14.73 and sold yesterday at $12.93 (close prices) for a 12% loss in two weeks (one of these 2 weeks was one of the most profitable in Wall Street history).
FSYS, on which Mr. Navellier spammed so much, was also bought on November 17th at around $32.75 and sold at around $27.90 for a 14% loss.
As you can see in the chart, from July 2008 the game is over and FRO started to nosedive until current $25.10 (what Navellier calls a rally).
In the best case Global Growth $5.000/paying subscribers once more witnessed navellier's magic to turn a 50% imaginary profit to a 43% realized loss.
Those unlucky and trustful readers who bought at $72 (as the icon of growth investing suggested) brought home a 65% loss.
Impressive...
PS: just a quick note: FRO is currently a BUY in Navellier's Portfolio Grader Pro...
Another spam from Navellier:
I wanted to be sure you knew:
At 11:59 p.m. tonight, the price of Emerging Growth automatically doubles. If you wish to join us tomorrow, it will cost you twice as much.
Act now and receive 3—yes 3 FREE timely investment research reports that create an ironclad money machine for you in 2009.
Plus, you snag Emerging Growth at our never-before-offered GIVEAWAY discount, saving you HALF-OFF—all if you act now.
If Not Now—When?
Small stocks are seeing BIG pops right now. Buying panic has gripped the innovators that populate the Emerging Growth Buy List. Just look at this action in the past few days:
“The stocks on the [Emerging Growth Buy List] provide the seeds for nearly all of the big winners of the future!”-Glenn M., Freemont , CA
If these are the best stocks in Navellier's portfolio...